Rationing By Any Other Name
“Rationing By Any Other Name” – The New England Journal of Medicine
“Rationing By Any Other Name” – The New England Journal of Medicine
Donald Trump says he can improve upon the Affordable Care Act – promising to get everyone in the country “a much better healthcare plan at much lower cost.” If that’s really what Trump wants to do, he should pay attention to one of the problems with Obamacare – the subsidies to purchase insurance might have…
Because so much of human thinking is dichotomous, even though so much of the real world exists on a continuum, we have strange phenomena like the one illustrated in the picture below. The picture shows the significance values of research findings, and reveals that there are many more articles published where the statistical significance of…
If you eat lots of meat, then you are contributing to global warming. Animals like cows require lots of grain, and they emit lots of methane; therefore, demand for hamburger increases CO2 emissions. Here’s a picture from the Washington Post illustrating how much we can reduce emissions by changing our diets:
Here is a fascinating picture from the Wall Street Journal, showing how much Medicare has been spending on hepatitis C treatments lately. You can see that the cost is rising dramatically: Keep in mind, however, that the new and expensive hepatitis C treatments currently on the market will dramatically reduce costs in the future, because…
In a recent post, I showed two drugs that were much more expensive in the United States than elsewhere. One was for rheumatoid arthritis and the other for hepatitis C. Today we get to look at a cancer drug, Avastin, and just how much more Americans pay for it than people in other countries. This…
Shutterstock How excited would you be about a medication that lowered your risk of cardiovascular death, heart attack, or stroke by 1.5%? Excited enough to spend a few thousand dollars a year on the drug? I expect not. What if, instead, the drug reduced those same terrible outcomes by 20%? That’s probably enough benefit to…